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Abstract
Background: High growth (hg) modifier and background independent quantitative trait loci (QTL)
affecting growth, adiposity and carcass composition were previously identified on mouse
chromosomes (MMU) 1, 2, 5, 8, 9, 11 and 17. To confirm and further characterize each QTL, two
panels of speed congenic strains were developed by introgressing CAST/EiJ (CAST) QTL alleles
onto either mutant C57Bl/6J-hg/hg (HG) or wild type C57Bl/6J (B6) genetic backgrounds.
Results: The first speed congenic panel was developed by introgressing four overlapping donor
regions spanning MMU2 in its entirety onto both HG and B6 backgrounds, for a total of eight
strains. Phenotypic characterization of the MMU2 panel confirmed the segregation of multiple
growth and obesity QTL and strongly suggested that a subset of these loci modify the effects of the
hg deletion. The second panel consisted of individual donor regions on an HG background for each
QTL on MMU1, 5, 8, 9, 11 and 17. Of the six developed strains, five were successfully characterized
and displayed significant differences in growth and/or obesity as compared to controls. All five
displayed phenotypes similar to those originally attributed to each QTL, however, novel
phenotypes were unmasked in several of the strains including sex-specific effects.
Conclusion:  The speed congenic strains developed herein constitute an invaluable genomic
resource and provide the foundation to identify the specific nature of genetic variation influencing
growth and obesity.
Background
The use of mouse models has provided valuable insight
into the etiology of monogenic syndromes caused by sin-
gle gene mutations. However, such models do not mimic
the genetic complexity of disease traits commonly seen in
the human population. Complex traits, such as polygenic
growth and obesity are influenced by the small to moder-
ate direct effects of quantitative trait loci (QTL), epistasis
between QTL alleles, environmental perturbations and
QTL-environment interactions.
To date numerous mouse growth and obesity QTL have
been localized [1,2], however, little progress has been
made in determining the specific nature of the underlying
genetic variants. One resource used to fine map QTL are
congenic strains which are designed to convert a complex
polygenic trait into one that is mono- or oligogenic. This
is accomplished by eliminating segregating genetic varia-
tion outside the locus of interest and reducing the envi-
ronmental variation influencing a trait by characterizing
large numbers of genetically identical mice. The Complex
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Trait Consortium (CTC) considers congenic analysis an
excellent method to confirm and subsequently fine map
QTL [3].
Traditionally, congenic strains are developed by intro-
gressing QTL alleles from a donor strain, whose bounda-
ries are defined by genetic markers, on the genetic
background of a recipient strain via 10 backcrosses [4].
While technically straightforward this is a time consuming
endeavor taking over three years to construct a single
strain. The speed congenic approach is an alternative to
this lengthy process and can reduce the number of
required backcrosses from 10 to five [5,6]. This strategy
uses marker-assisted selection to identify male mice inher-
iting fewer donor alleles, than expected on average, during
each backcross. Numerous traditionally developed and
speed congenics have been used to successfully isolate
mouse QTL for a wide array of traits, including growth
and obesity [7-13].
The C57Bl/6J-hg/hg (HG) mouse is a model of systemic
overgrowth resulting from a spontaneous deletion on
MMU10, which eliminates expression of the Socs2 (sup-
pressor of cytokine signaling 2) gene [14-16]. The role of
Socs2 in the HG phenotype was confirmed by an inde-
pendently engineered Socs2-/-  knockout mouse which
shared a number of phenotypes in common with HG,
including gigantism [17].
QTL which alter the phenotypic effects of another locus
are referred to as modifier QTL [18]. Modifier QTL have
been mapped for numerous traits and in these studies the
modified locus is typically a known gene containing a
spontaneously arisen or engineered mutation with major
phenotypic effects, such as hg [11,19-21]. Epistasis forms
the basis of these interactions, implying that the known
gene and its modifiers are members of the same biochem-
ical or metabolic pathway. Different genetic backgrounds
have been shown to modify the growth-enhancing effects
of hg [15,22]. Since the primary function of Socs2 is to
negatively regulate growth hormone (Gh) [23], it is likely
these background effects are the result of polymorphism
influencing interactions between members of the Gh sign-
aling pathway. Thus, identification of hg modifiers has the
potential to uncover novel members of metabolically
important pathways or previously unknown convergences
between pathways.
Table 1: B6.CAST and HG.CAST speed congenic strains developed to isolate and characterize genome-wide QTL affecting growth 
and obesity
QTLa MMU Peak LOD cM (Mbp)b Full congenic named Abbreviation Min. interval (Mbp)e
Wg1 2 31 (52) B6.CAST-(D2Mit1-D2Mit160)N(6) B62P 3.8–84.8
HG.CAST-(D2Mit1-D2Mit160)N(6) HG2P 3.8–84.8
B6.CAST-(D2Mit322-D2Mit439)N(6) B62PM 42.9–92.0
HG.CAST-(D2Mit322-D2Mit439)N(6) HG2PM 42.9–92.0
Wg2 25 9 – 8 3 c B6.CAST-(D2Mit329-D2Mit490)N(6) B62M 74.9–138.6
Carp1 (115–150) HG.CAST-(D2Mit329-D2Mit490)N(6) HG2M 74.9–138.6
Cara1 B6.CAST-(D2Mit329-D2Mit457)N(6) B62D 74.9–181.8
Feml1 HG.CAST-(D2Mit329-D2Mit457)N(6) HG2D 74.9–181.8
Q1Ucd1 -w26 1 16 (35) HG.CAST-(D1Mit118-D1Mit250)N(6) HG1 4.0–70.6
Carfhg1 5 38 (100) HG.CAST-(D5Mit229-D5Mit158)N(6) HG5 30.7–114.2
Wg3 8 45 (98) HG.CAST-(D8Mit9-D8Mit198)N(6) HG8 70.2–104.1
Carfhg2 9 10 (30) HG.CAST-(D9Mit249-D9Mit133)N(6) HG9 9.1–84.2
Feml2 9 20 (48) HG.CAST-(D9Mit249-D9Mit133)N(6) HG9 9.1–84.2
Carp2
Wg4
Cara2
11 46–50 (80–90) HG.CAST-(D11Mit260-D11Mit255)N(6) HG11 61.9–114.3
Feml3
Carp3
Cara3
17 46–48 (70–76) HG.CAST-(D17Mit213-D17Mit142)N(6) HG17 14.8–77.3
QTL, quantitative trait locus; MMU, mouse chromosome; LOD, log of the odds
a QTL MGI [59] nomenclature. Q1Ucd1-w26 never received an official MGI name, because it only reached a suggestive level of significance; hg 
modifier QTL are in bold [24].
b Mbp position according to the August 2005 mm7 UCSC [28] genome assembly (NCBI Build 35), peak LOD from [24].
c In the linkage analysis performed in [24], the peak location for Wg2, Carp1, Cara1 and Feml1 was 59–63 cM (115–120 Mbp) in hg/hg F2 mice and 
78–83 cM (135–150 Mbp) in +/+ F2 mice.
d Full congenic name consists of three parts: 1. B6.CAST, indicates the recipient strain is B6 and the donor strain is CAST; HG.CAST, indicates the 
recipient strain is HG and the donor strain is CAST; 2. markers defining the minimal congenic interval; 3. the number of backcrosses used for speed 
congenic development.
e Represents the minimum genomic region spanned by CAST donor alleles.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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As an initial step, growth and carcass composition QTL
were identified in a cross between CAST/EiJ (CAST) and
HG [24]. In the F2, mice homozygous for the hg deletion
(hg/hg) and wild type (+/+) were assayed and hg modifier
QTL were defined as those either absent in +/+ mice and
segregating in hg/hg  or loci with altered gene action
dependent on background. Four hg modifier QTL (Wg2
on MMU2, Carfhg2 on MMU9, Carp2 on MMU11 and
Feml3 on MMU17) were identified, along with 12 addi-
tional QTL (Q1Ucd1 on MMU1 (which only reached a
suggestive level of statistical significance), Wg1, Carp1,
Cara1 and Feml1 on MMU2, Carfhg1 on MMU5, Wg3 on
MMU8, Feml2 on MMU9, Wg4 and Cara2 on MMU11 and
Carp3 and Cara3 on MMU17) whose expression was inde-
pendent of the hg locus.
In the current study we have developed speed congenic
strains to isolate all the aforementioned QTL. Single
strains on an HG background were created for each chro-
mosomal region outside of MMU2, while a comprehen-
sive panel of overlapping strains with identical donor
regions on both B6 and HG backgrounds were developed
for MMU2. The MMU2 panel was developed to confirm
the presence of multiple QTL and test for QTL-hg interac-
tions. Additionally, based on the knowledge of potential
QTL-hg  interactions, genes involved in Gh  signaling,
whose genomic location overlapped hg modifier QTL on
MMU2, 9, 11 and 17, were sequenced.
Results
Speed congenic strain development
Two speed congenic panels were created, the first compre-
hensively dissected MMU2 while the second isolated QTL
on MMU1, 5, 8, 9, 11 and 17 (Table 1). The MMU2 panel
consisted of eight congenic strains developed by intro-
gressing four overlapping donor regions onto both B6 and
HG genetic backgrounds (Table 1). Single donor regions
bred onto an HG background were created to isolate the
remaining QTL on MMU1, 5, 8, 9, 11 and 17. Implemen-
tation of a speed congenic approach using marker-assisted
breeding with 79 genome-wide microsatellite markers
accelerated production of all strains [5,6] (Additional File
1 and Figure 1). Strain abbreviations and genomic region
isolated by each strain are listed in Table 1. In addition to
both congenic panels, two control strains homozygous B6
(B6.CASTC; B6C) or HG (HG.CASTC; HGC) for all
genome-wide markers genotyped were developed from
the same cross (see Methods) and served as the basis for
strain comparisons. After stabilizing each congenic, 12 of
14 were phenotypically characterized for growth and adi-
posity. The HG2D and HG5 strains were not characterized
due to reproductive problems. The recombinant end
points for all strains were refined using microsatellite
markers flanking each donor region (Additional File 2).
MMU2 speed congenic strain characterization
Due to the overlapping nature of the MMU2 congenics,
five distinct chromosomal regions (Regions I–V) were
queried for the presence of QTL (Figure 2). As a separate
analysis we also tested for interactions between each
donor region and the two distinct genetic backgrounds.
Outline of the speed congenic approach used to capture genome-wide growth and obesity QTL Figure 1
Outline of the speed congenic approach used to capture genome-wide growth and obesity QTL. Details of the 
congenic matings are outlined in "Methods". The matings used to construct the MMU2 speed congenic panel are listed on the 
left of the figure, along with the expected and observed % heterozygosity at each generation. % heterozygosity is defined as the 
number of markers heterozygous B6 (or HG)/CAST as a percent of the total number of markers typed (N = 79). The right 
side of the illustration lists the matings used to construct the MMU1, 5, 8, 9, 11 and 17 speed congenic strains, along with the 
expected and observed % heterozygosity at each generation.
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The following sections describe the phenotypes for each
B6.CAST and HG.CAST speed congenic strain as well as
the results of the interaction analysis.
B6.CAST MMU2 speed congenic strains
The B62D strain exhibited the largest (P < 0.0001)
decreases in body weight of any B6.CAST congenic (Addi-
tional File 3). Both sexes had reductions in weight at 2
(2WK), 3 (3WK), 6 (6WK) and 9 (9WK) weeks of age
compared to control B6C mice (Figure 3). Despite large
decreases in body weight, no differences in growth rates
(G26, weight gain from 2 to 6 weeks and G29, weight gain
from 2 to 9 weeks) were observed (Additional File 3).
Therefore, the B62D unique region (Region V) harbors
either an early-growth QTL or maternal genotype effect
which produces a distinct decrease in body weight prior to
2WK. These effects are evident in the growth curves for
both sexes of each strain (Figure 3). Additionally, B62D
mice displayed significantly shorter tail lengths despite no
difference in naso-anal length (NA) (Table 2).
In contrast, B62M mice displayed small decreases in body
weights and growth (male 9WK was significant, female
6WK and 9WK were suggestive at P < 0.05) and significant
Genome-wide speed congenic strains and summary of QTL effects Figure 2
Genome-wide speed congenic strains and summary of QTL effects. White bars indicate the boundaries of CAST 
donor regions and hatched bars indicate intervals of unknown genotype. The minimum physical intervals (Mbp) of each donor 
region are listed in Table 1. To provide a general summary of the results, MMU2 is divided into five chromosomal regions (I, II, 
III, IV and V). Phenotypic differences for male and female (+/+ and hg/hg) mice relative to the appropriate controls are listed. 
For congenics outside of MMU2, a general summary of QTL effects is listed to the right of each donor region. Abbreviations: 
WT, body weight; GR, growth rate; T, tail length; NA, nasal-anal body length; TF, total weight of four fat pads; AI, adiposity 
index and BMI, body mass index.
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Growth curves for MMU2 B6.CAST and HG.CAST speed congenic strains Figure 3
Growth curves for MMU2 B6.CAST and HG.CAST speed congenic strains. Body weight LSMEANS ± SEM are plot-
ted as a function of time (weeks). Top plot, growth curves in male B6 (+/+) and HG (hg/hg) speed congenic strains; bottom 
plot, growth curves in female B6 (+/+) and HG (hg/hg) speed congenic strains.
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decreases in NA (male P = 0.0152) and tail length (Addi-
tional File 3 and Table 2). The decrease in NA in B62M
mice is surprising since the 2M donor region is entirely
nested within the 2D donor region and B62D mice
showed no difference in NA (Figure 2). These data indi-
cate the presence of three QTL with the 2D unique region.
Two of which are disjoined by the B62M and B62D strains
and additively decrease body weight and tail length, but
not NA. The third QTL, located within the B62D unique
region (Region V), increases NA canceling the effects of
the B62M QTL (Region IV) decreasing NA.
B62PM females had decreases in all growth-related traits
except 2WK and 3WK, while no differences were seen in
males (Additional File 3). Similarly, only B62P females
and not males showed significant decreases in 9WK, G26
and G29 (Additional File 3), indicating these two strains
share a female specific growth QTL (Region II).
In the original genome scan body fat percentage as deter-
mined by chemical compositional analysis was not linked
to markers on MMU2 [24]. However, since numerous
obesity QTL have been found on MMU2 [2], some of
which were discovered in B6 by CAST crosses [9,25], we
chose to measure dissected fat pad weights as a more sen-
sitive measure of adiposity.
Table 2 lists the weights of gonadal (GFP), femoral (FFP),
mesenteric (MFP) and retroperitoneal (RFP) fat pads,
along with total fat pad weight (sum of the four fat pads),
adiposity index (AI = TF/weight at sacrifice (WSAC)) and
body mass index (BMI = WSAC/NA2  *100) for each
MMU2 congenic strain. Similar to large differences in
body weight the B62D strain displayed highly significant
decreases in adiposity. B62D was the only strain where
both sexes had significant decreases in TF, AI and BMI.
Interestingly, no difference in adiposity was seen in B62M
mice. This discordance indicates the leanness promoting
QTL is located in the B62D unique region (Region V).
Only minor differences in various fat pad weights were
observed for the B62P and B62PM strains (Table 2).
HG.CAST MMU2 speed congenic panel
HG2P and HG2PM mice of both sexes displayed signifi-
cant decreases in post-weaning body weights and growth
rates (Additional Table 3). In addition, the HG2M strain
displayed highly significant decreases in length, similar to
B62M mice (Table 2). These results indicate QTL within
Region II shared between the HG2P and HG2PM strains
decrease body size, weight gain and NA (only in females),
while a QTL in the HG2M region significantly decreases
tail length.
Similar to growth traits a general decrease in GFP, MFP,
RFP, TF and AI were seen in HG2P and HG2PM mice
(Region II) (Table 2). These differences in adiposity are
likely pleiotropic effects of the growth QTL shared
between these two strains. Surprisingly, HG2M mice dis-
Table 2: Body length and adiposity phenotypes of B6.CAST and HG.CAST MMU2 speed congenic strains
Strain Sex N NA (cm) Tail (cm) GFP (g) FFP (g) MFP (g) RFP (g) TF (g) AI (%) BMI
B6C M 29 9.1 ± 0.04 7.9 ± 0.04 0.344 ± 0.008 0.229 ± 0.006 0.183 ± 0.006 0.066 ± 0.002 0.823 ± 0.018 3.1 ± 0.1 31.6 ± 0.3
B62P M 20 9.2 ± 0.05 7.9 ± 0.04 0.309 ± 0.010 0.235 ± 0.007 0.178 ± 0.007 0.045 ± 0.003 0.768 ± 0.023 2.9 ± 0.1 30.8 ± 0.4
B62PM M 24 9.1 ± 0.05 7.8 ± 0.05 0.304 ± 0.010 0.222 ± 0.008 0.173 ± 0.007 0.046 ± 0.003 0.746 ± 0.024 2.9 ± 0.1 31.3 ± 0.4
B62M M 27 8.9 ± 0.07 7.4 ± 0.06 0.294 ± 0.014 0.239 ± 0.010 0.214 ± 0.009 0.066 ± 0.004 0.813 ± 0.032 3.2 ± 0.1 31.4 ± 0.5
B62D M 21 9.2 ± 0.06 7.1 ± 0.06 0.259 ± 0.013 0.177 ± 0.009 0.154 ± 0.009 0.038 ± 0.004 0.629 ± 0.030 2.6 ± 0.1 28.9 ± 0.5
B6C F 39 8.6 ± 0.03 7.6 ± 0.03 0.166 ± 0.007 0.202 ± 0.005 0.141 ± 0.005 0.027 ± 0.002 0.536 ± 0.016 2.6 ± 0.1 27.7 ± 0.3
B62P F 23 8.6 ± 0.05 7.8 ± 0.04 0.134 ± 0.010 0.224 ± 0.007 0.148 ± 0.007 0.023 ± 0.003 0.528 ± 0.022 2.7 ± 0.1 26.1 ± 0.4
B62PM F 20 8.4 ± 0.05 7.4 ± 0.05 0.139 ± 0.011 0.214 ± 0.008 0.154 ± 0.007 0.023 ± 0.003 0.530 ± 0.025 2.8 ± 0.1 26.9 ± 0.4
B62M F 32 8.4 ± 0.05 7.3 ± 0.05 0.153 ± 0.010 0.204 ± 0.007 0.165 ± 0.007 0.029 ± 0.003 0.551 ± 0.023 2.8 ± 0.1 27.9 ± 0.4
B62D F 23 8.7 ± 0.06 7.0 ± 0.06 0.110 ± 0.013 0.157 ± 0.009 0.135 ± 0.009 0.019 ± 0.004 0.420 ± 0.029 2.2 ± 0.1 25.0 ± 0.5
HGC M 31 10.2 ± 0.05 8.0 ± 0.05 0.477 ± 0.013 0.317 ± 0.008 0.297 ± 0.010 0.110 ± 0.005 1.201 ± 0.030 3.3 ± 0.1 35.0 ± 0.4
HG2P M 18 10.1 ± 0.07 8.2 ± 0.07 0.428 ± 0.019 0.326 ± 0.011 0.227 ± 0.014 0.069 ± 0.007 1.051 ± 0.043 3.1 ± 0.1 32.8 ± 0.5
HG2PM M 29 10.1 ± 0.05 8.0 ± 0.05 0.439 ± 0.014 0.303 ± 0.008 0.244 ± 0.010 0.082 ± 0.005 1.068 ± 0.031 3.1 ± 0.1 33.7 ± 0.4
HG2M M 31 10.1 ± 0.05 7.4 ± 0.05 0.469 ± 0.014 0.346 ± 0.008 0.306 ± 0.010 0.136 ± 0.005 1.260 ± 0.032 3.6 ± 0.1 33.9 ± 0.4
HGC F 23 9.6 ± 0.06 7.8 ± 0.06 0.369 ± 0.015 0.305 ± 0.009 0.268 ± 0.011 0.076 ± 0.005 1.020 ± 0.035 3.9 ± 0.1 28.2 ± 0.4
HG2P F 16 9.2 ± 0.07 7.8 ± 0.07 0.248 ± 0.018 0.311 ± 0.011 0.200 ± 0.013 0.044 ± 0.006 0.804 ± 0.041 3.4 ± 0.1 28.3 ± 0.5
HG2PM F 36 9.4 ± 0.04 7.7 ± 0.04 0.277 ± 0.012 0.265 ± 0.007 0.208 ± 0.009 0.046 ± 0.004 0.797 ± 0.027 3.2 ± 0.1 27.8 ± 0.3
HG2M F 28 9.6 ± 0.05 7.2 ± 0.05 0.329 ± 0.014 0.269 ± 0.009 0.247 ± 0.010 0.064 ± 0.005 0.909 ± 0.033 3.4 ± 0.1 29.3 ± 0.4
NA, nasal-anal body length; Tail, tail length; GFP, gonadal fat pad; FFP, femoral fat pad; MFP, mesenteric fat pad; RFP, retroperitoneal fat pad; TF, 
summed weight of four fat pads; AI, adiposity index (TF/body weight*100) and BMI, body mass index (body weight at sacrifice/NA2 *100). Values are 
expressed as LSMEANS ± SEM. LSMEANS in bold are significantly different than the respective control after Bonferroni correction (B6 (critical P < 
0.00625) or HG (P < 0.00833)) within each sex.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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played striking sex differences in adiposity. Males exhib-
ited an increase in AI (P = 0.0256) with a decrease in BMI
(P = 0.0462) and the exact opposite was seen in females
(AI, P < 0.0001; BMI, P = 0.0425) (Table 2). Therefore, the
obesity QTL in the HG2M unique region (Region IV) is
profoundly impacted by the presence of hg.
Confirmation of QTL-hg interactions
An important feature of our experimental design was the
ability to test for interactions between QTL in each MMU2
donor region and genotype at the HG locus, since identi-
cal donor regions were introgressed on two genetic back-
grounds, B6 (+/+) and HG (hg/hg). Significant
interactions between donor region and HG genotype were
viewed as strong evidence that hg modifier QTL reside
within that unique genomic region.
In the original linkage analysis the mode of gene action
and peak location of Wg2 were dependent on the presence
of  hg  [24] (Table 1). In the present study, only
homozygous congenic mice were characterized, thus, the
overdominant effects of Wg2 were not tested. However,
since its original peak location differed dependent on
background we hypothesized that Wg2 represents a set of
linked QTL between 74.9 and 181.8 Mbp within the 2M
and 2D donor regions (Region III–V), some of which
interact with hg. Following this logic we expected one or
both of these strains would exhibit donor region by HG
genotype interactions. Unfortunately, we were unable to
characterize HG2D mice. However, as noted above, strong
sex-specific effects were seen in HG2M mice. Significant
2M donor region by HG genotype by sex three-way inter-
actions for AI (P = 0.0004; Figure 4) and TF were identi-
fied (Table 3). The basis of these interactions was a
decrease in HG2M female and an increase in HG2M male
adiposity, with no differences in fat accumulation across
B62M sexes. Significant 2PM donor region by HG geno-
type two-way and 2PM donor region by HG genotype by
sex three-way interactions were also seen for TF and AI
(Table 3). In addition, significant 2P donor region × HG
genotype interactions were observed for all traits listed,
although some traits did reached significance at the criti-
cal P < 0.0071 (Table 3). The basis for each interaction was
a decrease in phenotype in HG2P compared to HGC and
no difference between B62P and B6C. Together these data
Table 3: Significance levels for the main effects, two-way and three way interactions of MMU2 speed congenic donor region (DR), HG 
genotype (HG) (+/+ or hg/hg) and sex for selected traits
Donor region 
(DR)a
6WK 9WK G26 G29 NA TF AI
Proximal (2P)
DR <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.0079
HG <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001
Sex <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.9840
DR*HG <.0001 0.0094 <.0001 0.0181 <.0001 0.0004 0.0183
DR*sex 0.0287 0.4783 0.0328 0.5938 0.0081 0.8780 0.5218
DR*HG*Sex 0.4092 0.4206 0.6957 0.0882 0.1563 0.1618 0.0219
Proximal middle 
(2PM)
DR <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001
HG <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001
Sex <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.7248
DR*HG 0.7101 0.4667 0.1277 0.1110 0.7375 0.0026 0.0065
DR*sex 0.1441 0.3947 0.1095 0.4198 0.0104 0.9323 0.6994
DR*HG*Sex 0.9437 0.2294 0.5748 0.0780 0.7697 0.0060 0.0002
Middle (2M)
DR 0.007 <.0001 0.0234 0.0002 0.0006 0.1703 0.9707
HG <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001
Sex <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.0064
DR*HG 0.0057 0.0563 0.1875 0.6072 0.4329 0.3437 0.0256
DR*sex 0.6968 0.0089 0.8356 0.0207 0.5162 0.1460 0.0437
DR*HG*Sex 0.6205 0.1309 0.6500 0.0656 0.6704 0.0035 0.0004
6WK, weight at 6 weeks of age; 9WK, weight at 9 weeks of age; G26, weight gain from 2 to 6 weeks of age; G29, weight gain from 2 to 9 weeks of 
age; NA, nasal-anal body length; TF, total fat pad weight and AI, adiposity index. Significant effects after a Bonferroni correction (critical P < 0.0071) 
are in bold.
a The distal (2D) donor region was not analyzed.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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confirm that MMU2 QTL modify the effects of the hg dele-
tion.
Speed congenic strains for QTL on MMU1, 8, 9, 11 and 17
HG1
Q1Ucd1 affecting G26 was the least significant of any QTL
identified in the original intercross and only reached a
suggestive level of significance (LOD = 2.46, P < 0.05)
[26]. In accordance, HG1 mice had small differences in all
growth and length traits. NA in both sexes and 2WK, 3WK,
6WK and tail length in females was significant at a critical
P < 0.005 (Table 4). The only difference in adiposity was
a significant decrease in male MFP (Table 5). The success-
ful capture and confirmation of the small effect Q1Ucd1-
w26 QTL adds support to pursuing QTL identified at sug-
gestive levels of statistical confidence from genome scans.
HG8
Markers on MMU8 were linked with G29 in the original
intercross [24]. This QTL was small, only accounting for
4.3% of the phenotypic variance. Interestingly, in HG8
mice no differences in growth were detected; however,
they were significantly leaner than controls (Table 5). In
males a general decrease in fat pad mass, TF and AI was
detected; however, only MFP was significant at a critical P
< 0.005. Male AI was nearly significant at a nominal P =
0.0082. Larger decreases in fat mass were seen in HG8
females, with significant decreases detected for GFP, MFP
and AI. Additionally, RFP and TF were nearly significant
with nominal P values of 0.0208 and 0.0153, respectively.
HG8 mice represent a lean congenic model in which CAST
alleles protect against fat accumulation.
HG9
CAST alleles in the proximal region of MMU9 were previ-
ously found to be linked with an increase in body fat per-
centage and a decrease in femur length [24]. The effects
appeared to be the result of two linked QTL, Carfhg2 at 10
cM and Feml2 at 20 cM, instead of one pleiotropically
impacting both traits (Table 1). In support of this, the
increase in fat was dependent on hg; however, differences
in femur length were not [24].
In confirmation of Carfhg2 all measures of adiposity in
HG9 mice were increased relative to control mice; except
MFP in both sexes and BMI in males (Table 5). In males,
GFP, RFP, FFP and AI were increased by 29.0%, 51.2%,
42.9% and 30.0%, respectively. In females these increases
were much larger. The same measurements were increased
by 68.8%, 99.4%, 69.7% and 57.3%, relative to HGC
females. A 2.9% and 3.6% reduction in male and female
NA, respectively, was also detected. This was expected
since NA was previously found to be an excellent indicator
of femur length (R2 = 0.88) in HG mice [27] and as noted
above this region contains the Feml2 QTL [24]. These data
confirm the effects of Carfhg2 on adiposity and Feml2 on
length and indicate the isolated effects of Carfhg2  are
more significant than originally observed.
HG11
In the original intercross CAST alleles near 50 cM on
MMU11 were linked with a reduction in G29, carcass ash
(ASH) and carcass protein (PROT) [24]. Therefore, we
measured each carcass component using chemical com-
positional analysis in the HGC, HG11 and HG17 strains.
Originally, Carp2 was dependent on the presence of hg
and no significant sex effects were detected [24]. In con-
trast to those results, HG11 mice displayed significant dif-
ferences in growth and obesity between the sexes. In
general, males demonstrated a 5% increase and females a
5% decrease in all growth-related traits (Table 4). Most of
these differences, however, were not significant at a criti-
cal P < 0.005, although almost all were at a nominal P <
0.05. Following the same trend, males displayed an
increase in tail length and a small suggestive increase in
NA (P = 0.06), while females displayed significant
decreases in NA. In support of the sex-specific QTL effects
strain by sex interactions (P < 0.04) were seen for the fol-
lowing growth traits: 3WK, 6WK, 9WK, G26, G29 and NA
(data not shown). The basis of each interaction was an
increase in the males and a decrease in females.
In our analysis of the HGC, HG11 and HG17 strains, con-
cordant results were observed measuring adiposity using
chemical lipid extraction and weighing fat pad mass. The
phenotypic correlation between carcass fat (FAT) as a per-
cent of the empty carcass weight (ECW; weight of total
body (including organs) minus the head and gastrointes-
Significant three-way donor region by HG genotype by sex  interaction for AI in the 2M donor region Figure 4
Significant three-way donor region by HG genotype 
by sex interaction for AI in the 2M donor region. AI 
plot illustrates the effect of the hg deletion on altering fat 
deposition between the sexes. The interaction is significant 
at P = 0.0004.
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tinal tract) (%FAT) determined by chemical analysis and
AI, using data from all three lines (HGC, HG11 and
HG17), was 0.92. These data suggest that individual fat
pad dissection is an excellent proxy for measuring whole
body adiposity and provides a much more sensitive tech-
nique to measure fat accumulation in specific body
regions.
HG11 females displayed slight increases in all fat pads
(except MFP) and AI, although, only the 16.5% increase in
AI was significant (Table 5). In contrast, HG11 males did
not show a difference in fat mass leading to a significant
strain by sex interaction (P = 0.008) for AI (data not
shown). Identical to the results obtained using fat pad
weights; female HG11 carcasses displayed an increase in
%FAT (Table 6).
HG11 male carcasses had higher levels carcass ash (ASH)
as a percent of ECW (%ASH) and female carcasses dis-
played lower levels of H2O and ASH (Table 6). Strains by
sex interactions (P < 0.005) were identified for H2O,
%H2O, %FAT, ASH and PROT (data not shown). If the
aggregate phenotype in HG11 is due to a single locus, its
function may be to disrupt energy partitioning by decreas-
ing the deposition of lean tissue and increasing lipid accu-
mulation in females, while having the opposite action in
males. However, it may also be due to distinct sex-specific
QTL with opposing action.
HG17
In the original intercross CAST alleles at MMU17 markers
were associated with decreases in femur length, ASH and
PROT [24] and similar results were seen in HG17 mice.
Table 4: Body size, growth rate and length phenotypes of HG.CAST speed congenic strains
Strain Sex N 2WK (g) 3WK (g) 6WK (g) 9WK (g) G26 (g) G29 (g) NA (cm) Tail (cm)
HGC M 31 7.4 ± 0.2 10.1 ± 0.3 30.4 ± 0.4 36.4 ± 0.4 23.1 ± 0.3 29.0 ± 0.4 10.2 ± 0.05 8.0 ± 0.04
HG1 M 19 6.9 ± 0.3 9.6 ± 0.4 28.8 ± 0.6 34.7 ± 0.6 21.9 ± 0.5 27.8 ± 0.5 9.9 ± 0.07 7.8 ± 0.06
HG8 M 15 6.7 ± 0.4 9.2 ± 0.5 29.7 ± 0.8 35.2 ± 0.8 23.1 ± 0.6 28.5 ± 0.7 10.2 ± 0.09 7.9 ± 0.08
HG9 M 29 6.8 ± 0.2 8.8 ± 0.3 27.6 ± 0.5 34.7 ± 0.5 20.7 ± 0.4 27.9 ± 0.4 9.9 ± 0.05 7.8 ± 0.05
HG11 M 23 7.8 ± 0.3 11.1 ± 0.4 31.7 ± 0.6 38.3 ± 0.6 23.8 ± 0.5 30.4 ± 0.5 10.4 ± 0.07 8.4 ± 0.06
HG17 M 10 8.4 ± 0.4 11.4 ± 0.6 29.0 ± 0.9 34.0 ± 1.0 20.7 ± 0.7 25.7 ± 0.8 9.9 ± 0.11 7.5 ± 0.09
HGC F 23 7.4 ± 0.2 10.1 ± 0.3 23.3 ± 0.5 25.9 ± 0.5 15.9 ± 0.4 18.5 ± 0.4 9.6 ± 0.06 7.8 ± 0.05
HG1 F 31 6.3 ± 0.2 8.2 ± 0.4 21.1 ± 0.5 24.7 ± 0.6 14.8 ± 0.4 18.3 ± 0.5 9.4 ± 0.06 7.5 ± 0.05
HG8 F 22 6.5 ± 0.4 8.7 ± 0.5 23.1 ± 0.8 26.0 ± 0.8 16.5 ± 0.6 19.5 ± 0.7 9.6 ± 0.09 7.6 ± 0.08
HG9 F 27 7.5 ± 0.2 9.7 ± 0.3 22.6 ± 0.4 25.7 ± 0.5 15.1 ± 0.3 18.2 ± 0.4 9.3 ± 0.05 7.6 ± 0.05
HG11 F 24 7.2 ± 0.2 9.6 ± 0.3 22.1 ± 0.5 24.8 ± 0.5 14.8 ± 0.4 17.5 ± 0.5 9.3 ± 0.06 8.0 ± 0.05
HG17 F 17 8.4 ± 0.3 11.0 ± 0.4 22.0 ± 0.6 25.2 ± 0.7 13.6 ± 0.5 16.8 ± 0.5 9.3 ± 0.07 7.4 ± 0.06
2WK, weight at 2 weeks of age; 3WK, weight at 3 weeks of age; 6WK, weight at 6 weeks of age; 9WK, weight at 9 weeks of age; G26, weight gain 
from 2 to 6 weeks of age; G29, weight gain from 2 to 9 weeks of age; NA, nasal-anal body length; Tail, tail length. Values are expressed as least 
square means (LSMEANS) ± SEM. LSMEANS in bold are significantly different than the control (HGC) (critical P < 0.005) after Bonferroni 
correction within each sex.
Table 5: Adiposity phenotypes of HG.CAST speed congenic strains
Strain Sex N GFP (g) FFP (g) MFP (g) RFP (g) TF (g) AI (%) BMI
HGC M 31 0.477 ± 0.020 0.317 ± 0.011 0.298 ± 0.010 0.110 ± 0.006 1.202 ± 0.042 3.3 ± 0.1 35.0 ± 0.3
HG1 M 19 0.473 ± 0.029 0.353 ± 0.016 0.258 ± 0.014 0.106 ± 0.009 1.190 ± 0.061 3.5 ± 0.2 35.2 ± 0.5
HG8 M 15 0.418 ± 0.038 0.340 ± 0.021 0.230 ± 0.018 0.099 ± 0.012 1.087 ± 0.080 3.0 ± 0.2 33.8 ± 0.6
HG9 M 29 0.615 ± 0.021 0.453 ± 0.012 0.283 ± 0.010 0.166 ± 0.007 1.518 ± 0.045 4.3 ± 0.1 35.6 ± 0.4
HG11 M 23 0.516 ± 0.027 0.312 ± 0.015 0.281 ± 0.013 0.120 ± 0.009 1.229 ± 0.058 3.2 ± 0.2 35.5 ± 0.5
HG17 M 10 0.540 ± 0.043 0.344 ± 0.024 0.278 ± 0.021 0.124 ± 0.014 1.285 ± 0.091 3.8 ± 0.3 35.1 ± 0.8
HGC F 23 0.370 ± 0.023 0.305 ± 0.013 0.269 ± 0.011 0.076 ± 0.007 1.020 ± 0.048 3.9 ± 0.1 28.1 ± 0.4
HG1 F 31 0.336 ± 0.025 0.328 ± 0.14 0.205 ± 0.012 0.055 ± 0.008 0.924 ± 0.053 3.8 ± 0.2 27.9 ± 0.4
HG8 F 22 0.247 ± 0.037 0.310 ± 0.021 0.193 ± 0.018 0.043 ± 0.012 0.793 ± 0.079 3.1 ± 0.2 27.8 ± 0.6
HG9 F 27 0.624 ± 0.021 0.518 ± 0.012 0.288 ± 0.010 0.152 ± 0.007 1.581 ± 0.045 6.1 ± 0.1 29.9 ± 0.4
HG11 F 24 0.436 ± 0.024 0.332 ± 0.014 0.269 ± 0.012 0.087 ± 0.008 1.124 ± 0.052 4.5 ± 0.2 28.5 ± 0.4
HG17 F 17 0.410 ± 0.029 0.350 ± 0.016 0.262 ± 0.014 0.086 ± 0.009 1.107 ± 0.062 4.4 ± 0.2 28.9 ± 0.5
GFP, gonadal fat pad; FFP, femoral fat pad; MFP, mesenteric fat pad; RFP, retroperitoneal fat pad; TF, summed weight of four fat pads; AI, adiposity 
index (TF/body weight*100) and BMI, body mass index (body weight at sacrifice/NA2 *100). Values are expressed as least square means (LSMEANS) 
± SEM. LSMEANS in bold are significantly different than the control (HGC) (critical P < 0.005) after Bonferroni correction within each sex.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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Interestingly, both sexes were heavier at 2WK (males, P =
0.0045; females, P = 0.0342), but lighter at 9WK, leading
to substantially lower G26 and G29 (Table 4). In general
growth differences ranged between 5% and 15% lower in
congenic mice.
Both sexes had significant reductions in length traits rela-
tive to control mice. NA was reduced by 2.7% (P =
0.0186) and 3.4% in males and females, respectively
(Table 4). In addition, tail was reduced by approximately
6% in both sexes (Table 4).
In general, HG17 mice displayed increases in all fat pads
(except MFP), TF and AI (Table 5). However, none of
these differences were significant at critical P < 0.005. In
addition, HG17 male carcasses possessed lower levels of
H2O and ASH, while female carcasses contained lower
levels of % H2O, ASH, %ASH and %PROT (Table 6).
MMU2, 9, 11 and 17 hg modifier candidate gene 
sequencing
The HG phenotype is due to the deletion of Socs2, there-
fore we reasoned that QTL on MMU2, 9, 11 and 17 inter-
acting with hg possibly represent variation within genes
participating in various aspects of Gh function. To select
candidate genes for sequencing we identified genes
known to be or potentially involved in Gh signaling, are
responsive to Gh or that propagate downstream Gh func-
tions. Forty-four hg modifier candidate genes were identi-
fied from primary literature, reviews and book chapters
and coordinated using the GenMAPP (Gene MicroArray
Pathway Profiler) pathway building software (Figure 5).
The coding region of each gene was sequenced from the
CAST strain and compared to the publicly available B6
sequence to identify polymorphisms (Additional File 4).
A total of 94.492 kbp was sequenced (75.378 kbp CDS
and 19.114 Kbp 5' and 3' untranslated region (UTR)), rep-
resenting 25,083 amino acids. Comparison with the pub-
lic B6 assembly (May 2004 University of California, Santa
Cruz (UCSC [28]) mm5 genome assembly, National
Center for Biotechnology Information (NCBI) Build 33)
identified 307 polymorphisms between CAST and B6. Of
these, 295 were single nucleotide polymorphisms (SNP)
and 12 were insertions or deletions in CAST (Additional
File 4). All 12 insertions or deletions were located within
5' and 3' UTRs. Fifty-six nonsynonomous SNP (nsSNP)
were identified in 14 different genes (Additional File 4).
PolyPhen [29] and SIFT [30] are software programs
designed to identify nsSNP which potentially alter protein
function by evaluating evolutionary conservation at spe-
cific amino acid residues using a multiple sequence align-
ment of protein sequences homologous to the query.
When applied to our data set PolyPhen, SIFT or both pro-
grams predicted that 15 of the 56 nsSNP in 9 different
genes would possibly alter protein function (Table 7).
Discussion
Speed congenic strains provide a powerful approach to
confirm and physically confine QTL within intervals
defined by molecular markers. In the current study,
approximately 20% of the CAST genome harboring all
previously detected growth and carcass composition QTL
was isolated on an HG or B6 background through the
development of 14 speed congenic strains. Two distinct
speed congenic panels were developed, the first provided
a comprehensive isolation of all MMU2 QTL between the
B6, HG and CAST strains and the second targeted all QTL
outside of MMU2. Each successfully characterized strain
exhibited phenotypic differences relative to control mice.
These strains represent important resources and provide
the genetic resource to positionally clone numerous quan-
titative trait genes.
One criticism of the speed congenic approach is the
potential for QTL to reside among unwanted donor alleles
not eliminated during backcrossing. In this case differ-
ences between the congenic and control strains would be
due in part or whole to these contaminating alleles. We
took several precautions to reduce the probability of this
occurrence. First, our control strains were developed from
Table 6: Carcass composition phenotypes of HG.CAST speed congenic strains
Line Sex N H2O (g) %H2O FAT (g) %FAT ASH (g) %ASH PROT (g) %PROT
HGC M 31 16.12 ± 0.30 57.74 ± 0.52 2.69 ± 0.11 9.77 ± 0.47 0.86 ± 0.01 3.08 ± 0.03 8.19 ± 0.08 29.41 ± 0.29
HG11 M 22 17.28 ± 0.35 58.62 ± 0.62 2.76 ± 0.13 9.43 ± 0.56 0.85 ± 0.01 2.89 ± 0.03 8.51 ± 0.10 29.06 ± 0.30
HG17 M 10 14.27 ± 0.55 55.32 ± 0.97 2.87 ± 0.21 11.34 ± 0.88 0.78 ± 0.02 3.02 ± 0.05 7.80 ± 0.15 30.33 ± 0.35
HGC F 23 10.08 ± 0.32 51.76 ± 0.56 2.66 ± 0.12 13.83 ± 0.51 0.68 ± 0.01 3.50 ± 0.03 5.95 ± 0.09 30.91 ± 0.27
HG11 F 22 8.95 ± 0.33 48.96 ± 0.58 2.94 ± 0.12 16.02 ± 0.53 0.58 ± 0.01 3.20 ± 0.03 5.80 ± 0.09 31.82 ± 0.32
HG17 F 17 8.88 ± 0.38 48.91 ± 0.67 2.84 ± 0.14 15.69 ± 0.61 0.60 ± 0.02 3.31 ± 0.04 5.80 ± 0.11 32.09 ± 0.50
H2O, carcass water; %H2O, water as a percent of carcass weight; FAT, carcass fat; %FAT, fat as a percent of carcass weight; ASH, carcass ash; 
%ASH, ash as a percent of carcass weight; PROT, carcass protein, %PROT, protein as a percent of carcass weight. Values are expressed as least 
square means (LSMEANS) ± SEM. LSMEANS in bold are significantly different than the control (HGC) (critical P < 0.0125) after Bonferroni 
correction within each sex.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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mice undergoing the same selection as all of the other
congenics. Therefore, it is possible that any unwanted QTL
or mutations arising during congenic construction are
shared between all strains. More importantly, we have
knowledge of all large previously detected growth and
obesity QTL in the current cross [24]. Using this informa-
tion we increased the density of markers in each QTL
region (MMU1, 2, 5, 8, 9, 11 and 17; Table 1 and Addi-
tional File 1), ensuring the absence of CAST alleles at each
of these QTL. This approach, termed "QTL-Marker-
Assisted Counter Selection" or QMACS, has been previ-
ously used to characterize QTL for hypnotic sensitivity to
ethanol [31]. In that study, only markers flanking QTL
were typed, not genome-wide markers. In contrast, we
selected not only against known QTL, we also screened for
genome wide heterozygosity increasing the probability
that effects observed are due to genetic variation within
each donor region.
Although great effort was put forth to eliminate non-
donor region direct genetic effects, other factors such as
maternal genotype (maternal genotype for each congenic
versus control dams differed) and environmental effects
could confound our results. Maternal genotype effects on
growth and obesity have been observed in a number of
mouse crosses [8,32-35] and their existence in the current
cross cannot be discounted. However, our congenics pro-
vide the ideal foundation genomic resource to test for the
influence of any of these possible effects. Future fine map-
ping experiments can be designed to randomize the influ-
ences of any contaminating donor alleles and
environmental differences, as well as test for maternal
genotype effects.
MMU2 is a hotspot for growth and obesity QTL. Over 30
QTL have been identified in various experiments [1,2].
Several previously reported or novel MMU2 QTL have
been isolated and characterized using congenic strains
[7,9-11,36]. Our findings are no different and indicate
that MMU2 is highly complex with regards to genes affect-
ing growth and obesity. The overlapping nature of our
MMU2 strains allowed us to parse the chromosome into
five regions (Regions I–V) (Figure 2). The data support the
presence of at least one QTL in each of the five regions
GenMAPP growth hormone (Gh) signaling pathway Figure 5
GenMAPP growth hormone (Gh) signaling pathway. Genes known to be or potentially involved in Gh signaling were 
mined from primary literature, reviews and book chapters. Genes are organized broadly based on functionality. MMU genomic 
position for each gene is to the right of each symbol and genes located on MMU2, 9, 11 and 17 are highlighted in yellow, pur-
ple, orange and green, respectively. Genes located on MMUX are labeled in white. Forty-four of the genes overlapping QTL 
intervals were selected for sequencing in the CAST strain.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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(Figure 2). Each of the five pleiotropically impact both
growth and obesity, although to varying degrees.
In addition to the large number of MMU2 QTL, the pres-
ence of hg adds complexity by either eliciting interactions
with the same QTL or by inducing the expression of novel
QTL. The 2P unique region (Region I) contains an hg
modifier with large effects on growth and smaller effects
on obesity (Table 3). In contrast, interactions between
2PM/2M QTL and hg primarily affect fat deposition (Table
3). As illustrated in Figure 4 the 2M donor region exhibits
strong sex effects on the rate of lipid storage, dependent
on background. In control mice, HGC females have a
higher AI than males, while the opposite is seen in B6C
mice. Interestingly, the 2M hg modifier QTL abolished the
hg induced sexual dimorphism in adiposity (Figure 4).
Although these results provide insight into the nature of
hg  modifier QTL, it should be noted, that the actual
number and precise location of loci is still unclear.
In addition to MMU2, three other congenics (HG9, HG11
and HG17) captured hg modifier QTL. In classical terms,
they are QTL which modify the expressivity of growth and
obesity in HG mice [18]. These QTL are novel since they
represent epistasis between hg  and the modifier gene.
QTL-hg epistasis implies that Socs2 and the hg modifiers
are in the same biological pathway. Therefore, these QTL
are likely due to polymorphism in genes interacting with
Gh, responsive to Gh or which in some way modulate Gh
function. This information will significantly aid QTL clon-
ing by providing another filter to screen candidates. Clon-
ing these QTL has major implications to improve our
understanding of Gh and its regulation of growth and adi-
posity and in the administration of human Gh therapeu-
tics.
HG1 mice displayed differences only in growth traits.
Originally,  Q1Ucd1  had small effects and these results
illustrate the power of congenic strain analysis to isolate
small effect QTL, although it is likely this QTL represents
the lower boundary of detection using only 20–30 con-
genic mice. The most notable candidate genes located
within the HG1 interval are the signal transducer and acti-
vator of transcription 1 (Stat1) and Stat4.
Two of the congenics had major alterations in the deposi-
tion of adipose tissue, HG8 and HG9. The HG8 donor
region promotes leanness. Congenic females displayed a
reduction of over 25% in AI. In contrast, the HG9 strain is
an obese mouse model. The strain is quite novel for two
reasons. First, the effect size is large; AI was 57% higher in
HG9 females and 30% higher in males. Secondly, it is
dependent on hg for its expression. The HG9 strain repre-
sents a major epistasis-based obese mouse model and
promises to aid in the understanding of obesity and spe-
cifically the modulation of adipose tissue deposition by
Gh. Studies are currently underway to identify the causa-
tive mutation and to characterize the effects of age and
diet on obesity in this strain as well as testing for other
physiological consequences such as alterations in food
intake and insulin sensitivity.
The HG11 strain is of particular interest for a number of
reasons. First, HG11 congenic mice demonstrated signifi-
Table 7: Nonsynonymous SNP in MMU2, 9 and 17 hg modifier candidate genes predicted by SIFT and Polyphen to alter protein 
function
Gene MMU Mbp AAÄa B6/CASTb 
Polyphen
CAST/B6 
Polyphen
B6/CAST SIFT CAST/B6 SIFT
Nmi 2 52.0 R243C B B T D
Mtx2 2 74.7 T1099M PSD PSD T D
Ubr1 2 120.6 A1371T B B D T
Ptpns1 2 129.3 H224N PBD PBD T T
Ubce7ip5 2 130.3 A314P PSD PSD T T
2 I366T B B T D
Plcg1 21 6 0 . 5 T 1 1 6 5 A B B T D
Mmp9 2 164.7 A514P B B D D
2P 6 3 9 L P B D P B D T T
Tyk2 9 21.0 R234H PSD PSD T T
C831S PSD PSD T T
T1099M PSD PSD T D
Vav 17 55.5 Q29H PSD PBD T T
Q53H PBD PSD T T
Q65H PBD PSD T D
MMU, mouse chromosome; AA, amino acid; PBD, probably damaging, PSD, possibly damaging; B, Benign; T, tolerated and D, deleterious.
a Amino acid change, first residue listed corresponds to the CAST allele and second corresponds to the B6 allele.
b Indicates which allele was designated as "mutant", i.e. B6/CAST, B6 allele is mutant and CAST is wild type.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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cant strain by sex interactions for a number of traits. Males
were generally larger, faster growing and longer and the
converse was seen in females. The confounding effects of
sex are likely the reason for the discrepancies between the
congenic and genome scan results, where both sexes were
analyzed together. Secondly, Carp2 was found to interact
with hg and MMU11 is saturated with genes involved in
the central Gh intracellular signaling pathway, such as Gh,
Stat5b and Stat5a. Thirdly, MMU11 growth QTL overlap-
ping HG11 have been identified in a number of crosses
using different mouse strains [37-41]. Given the well doc-
umented sexually dimorphic nature of Gh secretion and
Gh induced gene expression [42,43], it is probable that the
underlying mutation in the HG11 congenic may reside in
a gene enhancing Gh  induced sex-specific effects. The
structural Gh gene itself and Stat5b are excellent candi-
dates. The potential role of Gh would include polymor-
phism that alters protein function in the absence of Socs2
or that causes transcriptional deregulation of Gh. Addi-
tionally, functional variation in Stat5b may explain the
sex-specific phenotypes in HG11 mice since it is the pri-
mary transcription factor responsible for Gh induced sex-
specific liver gene expression [44]. Future studies aimed at
identifying the HG11 QTG, will certainly include a thor-
ough characterization of Gh  and  Stat5b  sequence and
expression patterns in congenic mice.
The hg modifier QTL located within the HG17 strain had
large effects on growth, body length and carcass compo-
nents. The most intriguing candidate gene located in the
congenic is Sstr5. Somatostatin is a potent inhibitor of Gh
and Sstr5  is one of five receptors which mediate these
effects [45,46]. Ubiquitous and pancreatic beta cell spe-
cific knockout of Sstr5 leads to alterations in insulin secre-
tion and glucose homeostasis [47,48].
We sequenced candidate hg modifier genes to comple-
ment the characterization of the speed congenics on
MMU2, 9, 11 and 17. A limited number of studies have
identified variation within CAST coding sequence; so
sequencing candidates gave us the opportunity to esti-
mate the SNP frequency in coding sequence relative to B6.
This information will be vital to future fine mapping stud-
ies, which will include gene expression analysis. The high
SNP frequency (0.312%; 295 SNP in 94.492 kbp) in CAST
genes may lead to a higher rate of false positives using
DNA microarrays or quantitative real-time PCR assays,
most of which are based on B6 sequence. Therefore, these
sequence data can be used to guide the development of
gene expression assays to confirm differential expression
for candidates and suggests that genes identified by down-
stream experiments should also be sequenced.
More importantly, sequencing hg  modifier candidates
allowed us to identify nonsynonomous polymorphism,
which may underlie QTL. SIFT and/or PolyPhen predicted
alterations in protein function for 15 of the 56 total
nsSNP (27%) in nine of the 44 total genes (20%) (Table
7). It has been shown that predicting function based on
evolutionary conservation using programs such as SIFT
and PolyPhen is very accurate [49]. Four of the nine genes
(Ubr1, Ptpns1, Ubce7ip5 and Mmp9; all of which are on
MMU2) are of particular interest. It has been suggested the
Socs2 may rely on ubiquitination dependent proteasomal
degradation to inhibit Gh  signaling [23]. Ubr1  and
Ubce7ip5 are both involved in protein ubiquitination and
Ubr1  knockout mice show an 20% decrease in body
weight partly due to a reduction in adipose tissue [50,51].
Ptpns1 knockout mice displayed a 10% reduction in body
weight [52] and Mmp9 knockout mice show a reduction
in size and drastically reduced bone length [53]. All of
these genes are excellent functional and positional hg
modifier candidate genes and this information can be
incorporated into future fine mapping studies.
Conclusion
The speed congenic strains developed herein confirm pre-
viously identified genome-wide QTL affecting growth,
obesity and carcass composition. Our novel congenic
development approach on MMU2 provided confirmation
of QTL-hg  interactions, which will significantly aid in
future fine mapping experiments. The identification of the
molecular mediators of QTL-hg epistasis as well as the
QTG for the remaining congenics will provide essential
information on the molecular genetic architecture of
growth and obesity.
Methods
Mouse strains and husbandry
CAST/EiJ (stock #000928) mice were purchased from the
Jackson Laboratory. The hg mutation was originally iden-
tified in a selected outcross line [22] and has been intro-
gressed onto a B6 background via nine backcrosses to
create the HG strain. HG mice used in this experiment
were from the 17th or later generation of inbreeding. Mice
were housed in polycarbonate cages under controlled
conditions of temperature (21°C ± 2°C), humidity (40–
70%) and lighting (14 h light, 10 h dark, lights on at 7
AM), and managed according to the guidelines of the
American Association for Accreditation of Laboratory Ani-
mal Care (AAALAC).
Genotyping
DNA for genotyping was isolated from 1.0–2.0 mm tail
clips by digesting with Proteinase K (Fisher) at 55°C in a
buffer composed of 0.45% NP40 (Sigma), 0.45% Tween
20 (Fisher) and 1X PCR buffer (Promega). The product of
this digestion was diluted (1:10) in sterile H2O and used
for genotyping without further purification. Microsatellite
genotyping was performed using standard PCR and gelBMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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electrophoresis protocols. Reaction conditions for each
marker are listed in Additional File 1 and 2.
MMU2 congenic mice were genotyped for hg using a two
primer genotyping assay. One primer set (HG-F, ctcctgtct-
gggctgtgag and HG-R, caaaggcagaagtggggtaa) spanned the
hg deletion producing a 447 bp product in hg/hg and +/hg
mice. The other set (CRADD3a.F, gtccatcagcattcctgaaa and
CRADD3.R, tgtccagcaacagcattgtc) amplified a 232 bp
Cradd amplicon (located within the hg deletion) in +/+
and +/hg mice [54]. The PCR annealing temperature was
55°C and the MgCl2 concentration was 1.5 mM.
Development of B6.CAST and HG.CAST MMU2 speed 
congenic strains
All speed congenic strains were developed starting with an
initial cross between a CAST male and HG females (Figure
1) [5,6]. Male F1  mice were then backcrossed to HG
females. All agouti (the dominant nonagouti (a) locus is
located at 154.8 Mbp on MMU2) N2 males were geno-
typed for 79 microsatellite markers (Additional File 1).
These markers were evenly spaced across the genome,
except in regions previously identified as harboring QTL
[1], which were more densely screened. The "best" N2
agouti male with the lowest level of genome-wide
unwanted heterozygosity while maintaining CAST alleles
for all MMU2 markers was selected for breeding. This
selection scheme was used at each generation until a N4
male was identified as homozygous HG for all markers
typed outside MMU2. After an additional backcross to HG
females, recombinant males were identified providing the
foundation for the four overlapping donor regions.
Selected recombinant males were then backcrossed to
both B6 and HG females to create strains, which were B6
(+/+) or HG (hg/hg) and heterozygous congenic. These
mice were intermated to produce homozygous founders
for each strain. This novel breeding scheme created four
identical founder congenics on two backgrounds B6 (+/+)
and HG (hg/hg), which formed the basis for our examina-
tion of interactions caused by the presence of the hg dele-
tion. MMU2 speed congenic strains were maintained
through brother-sister mating. Once each congenic was
stabilized, 20 additional microsatellite markers were used
to refine the position of each congenic recombinant end
point (Additional File 2).
Development of HG.CAST speed congenic strains for 
MMU1, 5, 8, 9, 11 and 17
All black N2 males from the first two crosses described
above were genotyped for 12 markers (D1Mit432, -480,
D5Mit353, -311, D9Mit60, -262, D11Mit5, -67, D8Mit234,
-211 and D17Mit28 and -142), two spanning each of the
six QTL harboring regions (MMU1, 5, 8, 9, 11 and 17;
Table 1 and Additional File 1). Markers were selected to
capture, at a minimum, the 2-LOD support interval. Two
N2 males were selected to propagate the N3 generation;
one heterozygous for QTL on MMU1 and 9 and the other
heterozygous for QTL on MMU5, 8, 11 and 17 (Figure 1).
Both males were homozygous for HG alleles at all other
known QTL. These males were backcrossed to HG females
and two of the resulting N3 males inheriting the same sets
of QTL as their sire were selected for breeding. These
males were subsequently backcrossed to HG females and
three N4 males were identified heterozygous for the fol-
lowing regions: 1) MMU1 and 9; 2) MMU5 and 11; 3)
MMU8, 11 and 17 (Figure 1). Starting at N4 and continu-
ing through N6, the "best" male with the lowest percent of
unwanted donor alleles was selected after performing a
genome scan using the remaining 67 genome-wide mark-
ers (79 total markers minus the 12 markers genotyped in
the first two backcrosses spanning the know QTL inter-
vals). At N5 a distinct strain was created for each of the six
individual donor regions and heterozygous mice were
intermated (Figure 1). Homozygous HG.CAST speed con-
genic strains were maintained through brother-sister mat-
ing. Once each congenic was stabilized, 19 additional
microsatellite markers were used to refine the position of
each congenic recombinant end point (Additional File 2).
Development of B6.CASTC and HG.CASTC control strains
HG is a strain in which the hg deletion has been intro-
gressed onto a B6 background, therefore the only genetic
differences between the strains would be the hg  locus,
tightly linked alleles from the outbred strain on which hg
arose and contaminating alleles remaining after the nine
backcrosses and fixed during inbreeding. Instead of using
parental B6 and HG strains as controls for phenotypic
comparisons with each speed congenic, we choose to
develop independent control strains originating from the
same cross as the congenic panels. Separate B6.CAST con-
trol (B6C) and HG.CAST control (HGC) strains were
developed using mice from the MMU2 experiment. Mice
from the last backcross inheriting only B6 or HG MMU2
alleles at markers spanning MMU2 were intermated to
serve as the basis for each control. Both control strains
were subsequently maintained through brother-sister
mating.
The control strains were coisogenic with the parental B6
or HG strain with the exception of mutations that arose
during congenic construction and a small percentage of
contaminating donor alleles missed after 6 backcrosses.
Therefore, since the congenics and controls were devel-
oped through the same selection scheme and possibly
share common contaminating regions, the B6C and HGC
strains are the most ideal control to compare each con-
genic.BMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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Phenotypic characterization
Trait data were collected on approximately 40 mice (20 of
each sex) from each congenic and control strain. To elim-
inate parity and reduce litter size effects only progeny
from uniparous dams were characterized and all litters
were standardized to 5–7 pups/litter. Mice were weaned at
3 weeks of age. Feed (Purina 5008; 23.5% protein, 6.5%
fat, 3.3 Kcal/g) and water were offered ad libitum. Mice
were weighed to the nearest 0.1 g at 2WK, 3WK, 6WK, and
9WK of age. At 9WK ( ± 5 days) mice were anesthetized
under isoflurane and nasal-anal length (NA) and nasal-
tail (NT) were measured to the nearest mm. Tail length
was calculated as NA minus NT. Anesthetized mice were
then sacrificed by decapitation and exsanguinated. Femo-
ral fat pad (FFP), gonadal fat pad (GFP), mesenteric fat
pad (MFP) and retroperitoneal fat pad (RFP) were
removed and weighed to the nearest mg.
Chemical compositional analysis was performed for
HGC, HG11 and HG17 carcasses as previously described
with slight modifications [24]. Briefly, after weighing each
fat pad was returned to the carcass. The entire gastrointes-
tinal (GI) tract was subsequently removed and carcasses
were again weighed. This represented the empty carcass
weight (ECW). Carcasses were labeled and secured in two
layers of cheesecloth (Fisher) and frozen at -20°C until
analysis. At this time, carcasses were freeze-dried for seven
days and water content was determined by subtracting the
freeze-dried weight from ECW. FAT was then extracted
with ether for 7 days, followed by acetone for an addi-
tional 7 days in a Soxhlet apparatus. Carcass ash (ASH)
was determined measuring the remains after a 16 hour
incineration at 575°C. Carcass protein (PROT) was calcu-
lated as the remaining portion after carcass fat (FAT) and
ASH were subtracted from ECW.
Statistical analysis
The MEANS and UNIVARIATE procedures of SAS were
used to generate descriptive statistics and test normality
assumptions for each trait [55]. All data were then ana-
lyzed using the GLM procedure of SAS [55] with a linear
model that included the fixed effects of strain, sex and
strain by sex interaction; dam's weight at breeding by
strain was used as a covariate. A second linear model was
used to test for strain by hg genotype (+/+ or hg/hg) inter-
actions. This model included the fixed effects of donor
region, sex and HG genotype and all possible two and
three-way interactions. Choosing a nominal P value of
0.05 and applying the Bonferroni correction for multiple
comparisons established significant differences in the
ANOVA's. The critical P values used are indicated in each
table.
Identification of candidate genes
Genes were identified by manual data mining of primary
literature, reviews and book chapters. To organize and col-
late genomic and functional information for each gene we
created a custom Gh signaling Gene Map Annotator and
Pathway Profiler (GenMAPP) pathway [56] (Figure 5).
Visualization and color-coding of genes using GenMAPP
aided the selection of candidate genes mapping within
QTL regions on MMU2, 9, 11 and 17.
Candidate gene sequencing
PCR amplicons covering the coding sequence and partial
5' and 3' untranslated regions for each selected candidate
gene were amplified, purified and sequenced from the
CAST strain using protocols outlined in [57] with slight
modifications. Total RNA from brain, liver, spleen, lung
and testis was isolated from an adult CAST male mouse
using Trizol (Ambion). cDNA was produced from total
RNA using standard procedures. PCR primer sets for each
gene were designed using Primer3 [58] (Additional File
5). The initial amplification was performed in 10 µl PCR
reactions using the Invitrogen Platinum TaqPCRx amplifi-
cation system (Invitrogen). The reactions contained 1X
PCR buffer, 1X Enhancer solution, 1.5 mM MgSO4, 0.17
mM dNTPs, 1 µM each primer, 0.1 unit of Platinum Taq
(Invitrogen) and approximately 25 ng of cDNA. Reactions
were incubated for 5 min at 95°C, then cycled for 45 s at
95°C, 45 s at 55°C, 1 min at 72°C for 35 cycles with a
final 72°C extension for 10 min on a MJ Research PTC-
200. The products were visualized on 1.5% agarose gels
containing 0.06 µg/ml EtBr. Bands of the correct size were
excised and incubated in 100 µl of sterile H2O at 80°C for
10 min to elute DNA. Reamplification reactions consisted
of 1X PCR buffer, 1.5 mM MgCl2, 0.17 mM dNTPs, 1 µM
each primer, 0.1 unit of Taq (Promega) and 10 µl of eluate
in a total volume of 50 µl. The same cycling parameters
were used for reamplification reactions. Products were vis-
ualized on 1% 0.5X TBE agarose gels containing 0.06 µg/
ml EtBr, excised and purfied using PCR purification col-
umns (Promega). To quantity each fragment 1 µl of each
purified product was run on a 1.0% agarose gel containing
0.06 µg/ml EtBr, along with a DNA mass ladder (Invitro-
gen). In a 96 well plate, 15 ng of each PCR product was
added to 5 pM of primer for sequencing. The College of
Agriculture and Environmental Sciences (CAES) Genom-
ics Facility at the University of California, Davis, per-
formed bidirectional sequencing of each amplicon.
Sequence analysis
B6 mRNA sequences for each gene were downloaded from
the May 2004 (mm5) UCSC (NCBI Build 33) genome
assembly [28]. These sequences were imported along with
all CAST sequence traces into the SeqMan sequence
assembly program (DNASTAR) and manually curated for
quality. Poor quality reads were resequenced. IndividualBMC Genomics 2006, 7:102 http://www.biomedcentral.com/1471-2164/7/102
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contigs were created for each gene and polymorphisms
were detected and curated by manual inspection.
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